Columbus, OH, United States of America

John W Christman


 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 40(Granted Patents)


Location History:

  • Houston, TX (US) (1996)
  • Columbus, OH (US) (2019 - 2023)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: John W Christman: Innovator in Peptide Inhibitors

Introduction

John W Christman is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of peptide inhibitors, particularly in the context of calcineurin-NFAT interactions. With a total of 4 patents to his name, Christman's work has implications for various therapeutic applications.

Latest Patents

One of Christman's latest patents focuses on peptidyl inhibitors of calcineurin-NFAT interaction. This patent describes peptides and peptide conjugates that comprise calcineurin binding motifs (CNBM) which inhibit the CN-NFAT interaction. The peptides may include a hydrophobic, non-peptidic moiety (RH) that interacts with the hydrophobic pocket on a calcineurin protein. The sequences involved can vary, allowing for flexibility in design and application.

Career Highlights

Throughout his career, John W Christman has worked with the Ohio State Innovation Foundation, where he has contributed to advancing research and innovation. His expertise in peptide chemistry and molecular interactions has positioned him as a key figure in his field.

Collaborations

Christman has collaborated with notable colleagues such as Dehua Pei and Manjula Karpurapu. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

John W Christman's contributions to the field of peptide inhibitors demonstrate his commitment to advancing scientific knowledge and therapeutic solutions. His innovative work continues to impact the landscape of biochemistry and pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…